Remdesivir dosing EUA for Pediatrics

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Thu, 02/03/2022 - 15:44
#1
Marina Rabin
Marina Rabin's picture
Offline
Last seen: 1 year 3 weeks ago
Joined: 12/10/2018 - 13:49
Remdesivir dosing EUA for Pediatrics

Trying to figure out the new EUA for Remdesivir for peds. More specifically the fact that EUA seems to addressthe following 3 out of 4 groups in terms of dosing:
1. > 12 yo and >40 kG - FDA approved
2. < 12 yo and > 40 kG
3. < 12 yo and < 40 kG
What do we do for 12-18 yo pediatric patient who weighs < 40 kG?

Is everyone taking EUA verbiage " This EUA is for the use of VEKLURY to treat COVID-19 in pediatric patients weighing 3.5 kg to less than 40 kg or ..." as defining pediatric patient as "0-18 yo" and just focusing on weight breakdown?

Top